The third dose of vaccine is scheduled to be administered at 14 weeks of age, but children presented at a median age of 18 weeks, which overlapped with the peak age of intussusception The third dose of vaccine is scheduled to be administered at 14 weeks of age, but children presented at a median age of 18 weeks, which overlapped with the peak age of intussusception Health Health News, Wellbeing Tips, Diseases, Treatment and Nutrition | The Hindu
Increased cases of Rotavac-induced intussusceptions after the third dose explained by background rates
